FDA label
What is Aranesp used for?
Aranesp contains darbepoetin alfa. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Aranesp lists 2 uses: Anemia Due to Chronic Kidney Disease; Anemia Due to Chemotherapy in Patients with Cancer.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Aranesp?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Aranesp, injection, solution
Indications and Usage, quoted from the label by Amgen, Inc (BLA103951). Cross-references to other label sections are left out.
Anemia Due to Chronic Kidney Disease
Aranesp is indicated for the treatment of anemia due to chronic kidney disease (CKD), including patients on dialysis and patients not on dialysis.
Anemia Due to Chemotherapy in Patients with Cancer
Aranesp is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.
Limitations of Use
Aranesp has not been shown to improve quality of life, fatigue, or patient well-being.
Aranesp is not indicated for use:
- In patients with cancer receiving hormonal agents, biologic products, or radiotherapy, unless also receiving concomitant myelosuppressive chemotherapy.
- In patients with cancer receiving myelosuppressive chemotherapy when the anticipated outcome is cure.
- In patients with cancer receiving myelosuppressive chemotherapy in whom the anemia can be managed by transfusion.
- As a substitute for RBC transfusions in patients who require immediate correction of anemia.
Source: DailyMed label, set id 0fd36cb9-c4f6-4167-93c9-8530865db3f9, version 161, effective July 7, 2026. NDC 55513-021, one of 9 listings for this product.
Questions
What is Aranesp used for?
The FDA label for Aranesp lists 2 uses: Anemia Due to Chronic Kidney Disease; Anemia Due to Chemotherapy in Patients with Cancer.
What drug class is Aranesp?
FDA lists darbepoetin alfa in the Erythropoiesis-stimulating Agent established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.